Published: 30 October 2022
Author(s): Carlo Perricone, Mirko Scarsi, Antonio Brucato, Paola Pisano, Erika Pigatto, Cecilia Becattini, Antonella Cingolani, Francesco Tiso, Roberto Prota, Lina Rachele Tomasoni, Maurizio Cutolo, Marika Tardella, Davide Rozza, Carlo Zerbino, Massimo Andreoni, Venerino Poletti, Elena Bartoloni, Roberto Gerli, COLVID-19 study group, under the auspices of the Italian Society of Rheumatology (SIR), the Italian Society of Infectious and Tropical Diseases (SIMIT) and the Italian Thoracic Society (ITS-AIPO)
Section: Original article
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) related disease (COVID-19) has caused one of the worst pandemics of modern times [1]. As of Sept 1st, 2022, the disease affected over 600,000,000 individuals and caused over 6,500,000 worldwide [2].
